University of Ottawa
University of Ottawa
Ottawa, Ontario, Canada5 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| SYNERGIC-2 Trial (SYNchronizing, Exercises and Remedies to GaIn Cognition@Home) | Cognition Disorders, Cognitive Dysfunction, Mild Cognitive Impairment, brain disorder, central nervous system disorder, cognitive disorder, dementia, nervous system disorder, psychiatric disorder | Recruiting | Not applicable | 2026-09-21 | NCT05375513 | |
| COgnitioN With VERiciGuat Evaluation in Heart Failure | Cognition Disorders, Cognitive Dysfunction, cardiovascular disorder, cognitive disorder, heart disorder, heart failure, psychiatric disorder | Recruiting | Phase 2 | 2026-08-25 | NCT06601465 | |
| Shorter and Safer Treatment Regimens for Latent TB | Actinomycetales infectious disease, Bacterial Infections and Mycoses, Infections, bacterial infectious disease, disease arising from reactivation of latent virus, gram-positive bacterial infections, latent tuberculosis infection, mycobacterial infectious disease, tuberculosis | Recruiting | Phase 2 / Phase 3 | 2026-05-11 | NCT06498414 | |
| ACT-GLOBAL THROMBOLYSIS (ACT-WHEN-001) Domain Within the ACT-GLOBAL Adaptive Platform Trial-NCT06352632 | brain disorder, cardiovascular disorder, central nervous system disorder, cerebrovascular disorder, ischemic stroke, nervous system disorder, stroke disorder, vascular disorder | Recruiting | Phase 3 | 2025-09-17 | NCT06320431 | |
| Study of Iomab-B vs. Conventional Care in Older Subjects With Active, Relapsed or Refractory Acute Myeloid Leukemia | Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, acute myeloid leukemia, hematologic disorder, leukemia, myeloid leukemia, neoplasm | Active, not recruiting | Phase 3 | 2023-07-19 | NCT02665065 |